Global Cause
Infectious Diseases Q3 2022
-
What we know about Chagas disease and how to address its challenges
Chagas disease, also known as American trypanosomiasis, is a potentially life-threatening illness caused by the protozoan parasite Trypanosoma cruzi. What do we know about Chagas disease? About 6–7 million people worldwide are estimated to be infected with T. cruzi. The disease is prevalent in endemic regions of 21 Latin American countries, where it is transmitted...
-
Hepatitis can’t wait any longer for global action
We are running out of time to reach the goal of eliminating hepatitis by 2030. It will take increased commitment by governments and global institutions to make it happen. At the recent World Hepatitis Summit, the Director-General of the World Health Organization (WHO), Dr Tedros Adhanom Ghebreyesus stated, “There are few diseases that we can...
-
Millions of people hit with long Covid may have to live with it for years to come
Countries are urged to take post Covid-19 condition seriously by urgently investing in research, recovery and rehabilitation. New modelling conducted for WHO/Europe by the Institute for Health Metrics and Evaluation (IHME) at the University of Washington’s School of Medicine in the United States shows that in the first two years of the pandemic, at least...
-
s Sponsored
How today’s virology leaders are preparing for the future
Investing in virology innovation and collaboration today will enable a rapid and effective response to the next global health threat. Following Covid-19, virology expert Frank Duff warns that a future viral threat “will almost certainly arrive” and acknowledges that no single organisation, agency, or government can tackle this alone. Key partnerships Underlining the importance of...
-
s Sponsored
Advancing global health equity through inclusion
From endemics to pandemics, involving community voices directly in the research process can help drive more equitable care. The world is experiencing a convergence of urgent viral threats, from the longer-standing HIV and hepatitis epidemics to the Covid-19 pandemic and the emerging monkeypox public health emergency. While scientific innovation has advanced the response to these...
-
s Sponsored
Why cross-sector collaboration is critical to public health
Overcoming emerging viruses is a global challenge that reaches beyond medicine. While vaccines and antiviral treatments are important tools to address viral outbreaks, virology specialist Frank Duff believes it will take more to address the world’s toughest healthcare challenges. Stigma and discrimination are common barriers to care for the communities most impacted. Partnership is key...
-
s Sponsored
How to fix the broken funding model for new antibiotic discovery
Governments must pay for antibiotics with a subscription-for-access model offering developers appropriate reimbursement, regardless of how many drugs are used. Two things can tackle the antimicrobial resistance (AMR) crisis, notes Aleks Engel. “The first is better stewardship of antibiotic use,” he says. “That might slow the spread of antimicrobial resistance genes. Second, we have to...
-
Antimicrobial resistance: the rise of a ‘silent pandemic’
If the pandemic has taught us one thing, it is that we are not prepared to combat the serious threat that emerging infectious diseases can pose to human health and our economies. All deficiencies revealed with COVID-19 have long been recognised in the fight against antimicrobial resistance (AMR). I hope that the main lesson learned...
-
Eliminating tuberculosis by 2030: abandon the goal or revise the strategy?
Despite bold commitments and tuberculosis (TB) elimination strategies, we are not on track to end TB by 2030. As the deadline gets ever closer, we have come to a crossroads. Back in 2015, world leaders committed to ending the tuberculosis (TB) epidemic globally by 2030. Fast-forward three years and these commitments were reaffirmed at the...